FR2368949A1 - ERYTHROMYCIN ANTIMICROBIAL PRODUCT FOR THE TOPICAL TREATMENT OF ACNE DISORDERS - Google Patents

ERYTHROMYCIN ANTIMICROBIAL PRODUCT FOR THE TOPICAL TREATMENT OF ACNE DISORDERS

Info

Publication number
FR2368949A1
FR2368949A1 FR7732761A FR7732761A FR2368949A1 FR 2368949 A1 FR2368949 A1 FR 2368949A1 FR 7732761 A FR7732761 A FR 7732761A FR 7732761 A FR7732761 A FR 7732761A FR 2368949 A1 FR2368949 A1 FR 2368949A1
Authority
FR
France
Prior art keywords
erythromycin
topical treatment
antimicrobial product
acne
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7732761A
Other languages
French (fr)
Other versions
FR2368949B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of FR2368949A1 publication Critical patent/FR2368949A1/en
Application granted granted Critical
Publication of FR2368949B1 publication Critical patent/FR2368949B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Abstract

Produit antimicrobien destiné au traitement topique des affection acnéiques. Ce produit contient fondamentalement une quantité efficace d'érythromycine ou d'un composé ou dérivé de celle-ci et un support ou véhicule pharmaceutiquement acceptable, doué de propriétés particulières de pénétration dans la peau et contenant de 0 à environ 5 % de monooléate de glycérol, de 20 à 80 % environ d'éthanol, et le reste étant du myristate d'isopropyle, avec éventuellement des adjuvants tels que colorants, epaississants, ou autres. Traitement de toutes les lésions acnéiformes.Antimicrobial product for the topical treatment of acne conditions. This product basically contains an effective amount of erythromycin or a compound or derivative thereof and a pharmaceutically acceptable carrier or vehicle, endowed with particular skin penetrating properties and containing 0 to about 5% glycerol monooleate , from 20 to 80% approximately ethanol, and the remainder being isopropyl myristate, optionally with adjuvants such as dyes, thickeners, or others. Treatment of all acneiform lesions.

FR7732761A 1976-11-01 1977-10-28 ERYTHROMYCIN ANTIMICROBIAL PRODUCT FOR THE TOPICAL TREATMENT OF ACNE DISORDERS Granted FR2368949A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73731576A 1976-11-01 1976-11-01

Publications (2)

Publication Number Publication Date
FR2368949A1 true FR2368949A1 (en) 1978-05-26
FR2368949B1 FR2368949B1 (en) 1979-07-20

Family

ID=24963418

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7732761A Granted FR2368949A1 (en) 1976-11-01 1977-10-28 ERYTHROMYCIN ANTIMICROBIAL PRODUCT FOR THE TOPICAL TREATMENT OF ACNE DISORDERS

Country Status (10)

Country Link
JP (1) JPS5394030A (en)
BE (1) BE860349A (en)
CA (1) CA1090253A (en)
DE (1) DE2748399C2 (en)
FR (1) FR2368949A1 (en)
GB (1) GB1587428A (en)
IE (1) IE45902B1 (en)
IT (1) IT1088874B (en)
NL (1) NL179185C (en)
PH (1) PH15370A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027286A2 (en) * 1979-10-12 1981-04-22 THE PROCTER & GAMBLE COMPANY Anti-acne composition comprising diisopropyl sebacate
EP0091964A1 (en) * 1981-09-28 1983-10-26 Nitto Denko Corporation Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent
EP0305026A2 (en) * 1987-08-24 1989-03-01 Alza Corporation Transdermal drug delivery device with dual permeation enhancers

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378523A1 (en) * 1977-01-26 1978-08-25 Grupper Charles ACNE TREATMENT MEDICINE
IT1210608B (en) * 1980-12-08 1989-09-14 Rorer Int Overseas COMPOSITION FOR TOPICAL ACNE TREATMENT
JPH0764754B2 (en) * 1984-10-02 1995-07-12 花王株式会社 Transdermal absorption enhancer and external preparation for skin containing the same
LU86393A1 (en) * 1986-04-16 1987-12-07 Oreal STABLE ANTI-ACNE COMPOSITION BASED ON ERYTHROMYCIN
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
DE4334553C2 (en) * 1993-10-11 1998-05-20 Synopharm Gmbh Pharmazeutische Liquid pharmaceutical system for percutaneous application
SI2079441T1 (en) * 2007-07-25 2010-12-31 Ixodes Gmbh Topical antibiotic composition for the prevention of lyme disease
EP4308248A1 (en) * 2021-03-16 2024-01-24 Unilever IP Holdings B.V. Cosmetic skin care composition

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2914443A (en) * 1958-03-31 1959-11-24 Abbott Lab Ointment
GB903256A (en) * 1958-11-27 1962-08-15 Mundipharma Ag Improvements in novel otologic preparations and the process for their preparation
GB1048820A (en) * 1963-05-29 1966-11-23 Merck & Co Inc Emollient compositions containing liquid fatty acid esters
FR2164802A1 (en) * 1971-12-23 1973-08-03 Merck & Co Inc
DE2615140A1 (en) * 1975-04-11 1976-10-21 Nelson Res & Dev VEHICULUM SYSTEM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA945068A (en) * 1967-10-25 1974-04-09 Albert M. Kligman Composition and method of treating acne

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2914443A (en) * 1958-03-31 1959-11-24 Abbott Lab Ointment
GB903256A (en) * 1958-11-27 1962-08-15 Mundipharma Ag Improvements in novel otologic preparations and the process for their preparation
GB1048820A (en) * 1963-05-29 1966-11-23 Merck & Co Inc Emollient compositions containing liquid fatty acid esters
FR2164802A1 (en) * 1971-12-23 1973-08-03 Merck & Co Inc
DE2615140A1 (en) * 1975-04-11 1976-10-21 Nelson Res & Dev VEHICULUM SYSTEM

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027286A2 (en) * 1979-10-12 1981-04-22 THE PROCTER & GAMBLE COMPANY Anti-acne composition comprising diisopropyl sebacate
EP0027286A3 (en) * 1979-10-12 1981-05-13 The Procter & Gamble Company Anti-acne composition and method
EP0091964A1 (en) * 1981-09-28 1983-10-26 Nitto Denko Corporation Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent
EP0091964A4 (en) * 1981-09-28 1985-07-01 Nitto Electric Ind Co Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent.
EP0305026A2 (en) * 1987-08-24 1989-03-01 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
EP0305026A3 (en) * 1987-08-24 1990-02-14 Alza Corporation Transdermal drug delivery device with dual permeation enhancers

Also Published As

Publication number Publication date
IE45902L (en) 1978-05-01
IT1088874B (en) 1985-06-10
JPS5394030A (en) 1978-08-17
NL7712005A (en) 1978-05-03
NL179185B (en) 1986-03-03
CA1090253A (en) 1980-11-25
DE2748399A1 (en) 1978-05-11
PH15370A (en) 1982-12-10
GB1587428A (en) 1981-04-01
DE2748399C2 (en) 1983-09-15
FR2368949B1 (en) 1979-07-20
BE860349A (en) 1978-05-02
IE45902B1 (en) 1982-12-29
NL179185C (en) 1986-08-01

Similar Documents

Publication Publication Date Title
FR2368949A1 (en) ERYTHROMYCIN ANTIMICROBIAL PRODUCT FOR THE TOPICAL TREATMENT OF ACNE DISORDERS
FR2416012A1 (en) DERIVATIVES OF IMIDAZOLE AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
BE904734A (en) TOPICAL COMPOSITIONS FOR THE TREATMENT OF SKIN BASED ON SALICYLIC ACID DERIVATIVES.
FR2398493A1 (en) NEW 2,4-HEXADIAN DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS COSMETIC AGENTS
FR2379283A1 (en) COSMETIC PRODUCTS CONTAINING MOISTURIZING AGENTS FOR THE SKIN
BE605871A (en) Process for the preparation of storage stable liquid concentrates containing active oxygen
BE903183A (en) NOVEL BENZONORBORNENE DERIVATIVES, PREPARATION METHODS THEREOF, AND MEDICINAL AND COSMETIC COMPOSITION CONTAINING THEM
FR2361901A1 (en) NUCLEOTIDES SUBSTITUTION DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
CH670450A5 (en)
FR2541115B1 (en) MEDICAMENT CONTAINING PEPTIDE AS ACTIVE INGREDIENT FOR THE TREATMENT OF ULCEROUS CONDITIONS
KR890011838A (en) 16-dehydrovitamin D₃-derivative
CA1229792A (en) Anti-acneic composition containing an isothiazolo- (5-4b) pyridine one-3 derivative as active ingredient
CA1300131C (en) Antibiotics retinoid esters, their preparation process and pharmaceutical and cosmetical compositions containing them
FR2405067A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING MONOFUNCTIONAL DERIVATIVES OF PSORALENE FOR THE TREATMENT OF SKIN DISORDERS
KR950003262A (en) 1-aryloxy-3-alkylamino-2-propanol nitrate esters, uses thereof and corresponding pharmaceutical compositions
KR910700230A (en) New hydroxylamine derivatives
FR2429019A1 (en) DRUGS CONTAINING 1-B-D-ARABINOFURANOSYLCYTOSINE-5'-PHOSPHATE ESTERS
FR2428436A1 (en) NOVEL COSMETIC COMPOSITIONS FOR THE TREATMENT OF FATTY CONDITIONS OF HAIR AND SKIN, NOVEL COMPOUNDS AND THEIR PREPARATION METHOD
KR880002518A (en) Anti-inflammatory composition
FR2453152A1 (en) NEW PROSTAGLANDIN DERIVATIVES AND MEDICAMENTS CONTAINING THEM
AR007297A1 (en) A COMPOUND DERIVED FROM 5-AROIL-PIRROL-2-ILMETILARENO, MEDICINES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND USES THEREOF.
FR2363324A1 (en) AQUEOUS OR HYDROALCOOLIC STABLE SOLUTIONS OF PERFUMED ESSENCES OR OIL SOLUBLE MEDICINAL PRODUCTS
FR2355012A1 (en) NEW DERIVATIVES OF DIHYDRO- AND TETRAHYDRO-IMINOTHIAZINE, AND THEIR APPLICATION AS MEDICINAL PRODUCTS
BE900138A (en) PHARMACEUTICAL OR VETERINARY COMPOSITION FOR COMBATING CARDIAC ISCHEMIC DISORDERS.
FR2435945A1 (en) IMPROVEMENTS IN COMPOSITIONS CONTAINING ETOMIDATE

Legal Events

Date Code Title Description
ST Notification of lapse